Table 2 Surgical data and postoperative complications

Operative priority

67

   Elective

45 (67.2%)

   Urgent

15 (22.4%)

   Emergency

4 (6%)

   Salvage

3 (4.5%)

Number of operations

67

   First

56 (83.6%)

   Second

10 (14.9%)

   Third

1 (1.5%)

Type of aortic valve lesion

67

   Stenotic

18 (26.9%)

   Regurgitant

35 (52.2%)

   Mixed

14 (20.9%)

Explanted valve

67

   Native

52 (77.6%)

   Bioprosthesis

7 (10.4%)

   Mechanical

7 (10.4%)

   Homograf

1 (1.5%)

Aortic valve pathology

67

   Calcific degeneration

29 (43.3%)

   Myxomatous degeneration

11 (16.4%)

   Prosthetic valve failure

9 (13.4%)

   Congenital

5 (7.5%)

   Annuloaortic ectasia

3 (4.5%)

   Dissection

3 (4.5%)

   Infection

2 (3%)

   Rheumatic

1 (1.5%)

   Other degenerative

1 (1.5%)

   Unknown

3 (4.5%)

Pathology of the aorta

67

   Aneurysm

54 (80.6%)

   Dissection

9 (13.4%)

   Infection

4 (6%)

No-React ^® BioConduit size

67

   20

1 (1.5%)

   21

5 (7.5%)

   23

7 (10.4%)

   25

23 (34.3%)

   27

24 (35.8%)

   29

4 (6%)

   31

1 (1.5%)

   Unknown

2 (3%)

Other cardiac procedures

67

   CABG

17 (24.4%)

   Replacement/repair of other valves

3 (4.5%)

   LV Aneurysmectomy

1 (1.5%)

   Other procedures

5 (7.5%)

CBP time (min); mean (SD)

65

183 (86)

Range: 96-554

CPB time (P25, P50, P75)

135; 155; 207

Aortic XC time (min); mean (SD)

65

130 (45)

Range: 63-275

Aortic XC time (min) (P25, P50, P75)

99.5; 117; 146.5

Circulatory arrest time; mean (SD)

28

33.71 (17)

Range: 4-69

Circulatory arrest time (P25, P50, P75)

24.2; 28.5; 43.7

Postoperative complications

   Atrial fibrillation

67

17 (25.4%)

   Low cardiac ouput

67

11 (16.4%)

   Renal complication

67

5 (7.5%)

   Neurological

67

3 (4.5%)

   Implantation of PPM

67

3 (4.5%)

   Pulmonary

67

2 (3%)

   Infective complications

67

2 (3%)

   G.I. complications

67

2 (3%)

   Re-sternotomy for bleeding

67

2 (3%)

   Sternal resuturing

67

1 (1.5%)

   Readmitted to ITU

67

1 (1.5%)